Results: BDEV

Search articles by EPIC code
EPIC BDEV
views

Barratt Boosts Business in Spite of Headwinds and should Build its Share Price

Hello Share Grumblers. It becomes ever harder for a bull trader like myself to find possible winners as the Footsie drops further week by week. But there are some promising sectors out there. And those, despite reservations from Uncle Tom, look to me to include the house building game. Take Barratt Developments (BDEV) for example. It sold nearly 18,000 homes in its latest year.

EPIC BDEV
views

Thursday analytical insights with Barratt Developments and Ashmore Group

If I had to bet, then I would say that Thursday is the busiest analytical day for any investor, analyst or fund manager. There is a different angle today however in a bunch of UK numbers: trading updates for the period ended 30th June, which are fully responded too in September. Such (future) excitement! First up is Barratt Developments (BDEV), the homebuilder whose shares I am sure many of you may own but I don’t think I ever have.

EPIC BDEV
views

I bet Barratt’s chairman wishes it was already (permanent) personal holiday time

You may have heard the other day that the latest Nationwide house price survey observed that apparently annual house prices rose by 11.2% in May, making the average UK home costs £269,914…or a mere 6.9 times average earnings.  I am sure many people are excited about this but most probably know the reality of significantly slowing - if any! - house price growth over full year 2022.  Spot the impact of higher interest rates and a slowing economy… And on possibly related factors I read in the press today that the “titan housebuilder Barratt (BDEV) is planning to begin a search for a new chairman, with City grandee John Allan to step down”. 

EPIC BDEV
views

Whilst I wait for GlaxoSmithKline to split itself…more on the UK housing market via Barratt Developments

I am looking forward to the GlaxoSmithKline (GSK) conference call later today. Whilst technically it is focused on the full year 2021 numbers out earlier today (which showed rising sales and falling profits), far more important is the confirmation that it is ‘on track to demerge a new world-leading Consumer Healthcare business mid-2022’. Last month I was amused by the (ultimately unsuccessful) partial bid approach by Unilever (ULVR) but my instinct is that the Pharmaceutical / Vaccines business is still underappreciated going forward. I was certainly pleased to see the ‘pipeline of 21 vaccines and 43 medicines’ angles and I do wonder - when the business split occurs in a few months time - whether not only retaining but adding to this part of the business. Something to be more thoughtful about later this year whilst, despite the excellent total return performance over the last year, I remain a strong HOLDer. So whilst I continue to hang onto my GlaxoSmithKline shares…what do I make of today’s interim results announcement from FTSE 100 housebuilder Barratt Developments (BDEV)?...

EPIC BDEV
views

Barratt Developments shareholders need to note too much anticipated house price excitement in 2022

I see there is more comedy occurring in the energy sector as yet another company - the wonderfully named Zog Energy - collapsed. I have never heard of it but given I recall ‘Zog’ as a 2010 children's picture book about a young accident-prone dragon which I think both my daughters at some time read, you have to smile at the choice of its name. Yet another energy company which needs to fully understand that not being sensibly hedged means you can be materially exposed to any price volatility. Meanwhile as Ofgem put it following a collective four million household problem “under our safety net we'll make sure your energy supplies continue...You can rely on your energy supply as normal”. Far smarter if Ofgem also tells all customers that simply trying to find the cheapest short-term company is not smart. Still, you cannot regulate everything otherwise we would not also have shares that exhibit either too much fear or (more recently) too much greed judging by their crazy multiples. At the moment I am trying to work out which side housebuilding stocks are in.

EPIC BDEV
views

Barratt Unperturbed by Rising Raw Material Costs and Shortages so the Future Looks Sparkly

Hello, Share Slammers. This old punter has been saying for some months that Blighty’s house builders are likely to see further rising share prices as something of a boom is going on. Well, one of them Barratt Developments (BDEV) has just issued a three month trading statement that says it’s having ‘a strong and sustained start to the new financial year’.

Page 1 of 7 (68 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments